Turkey is force-liquidating 130 investment funds worth about $20 billion over six months — and the crackdown may be what keeps it in the emerging-market index

On September 17, 2026 Turkey’s Capital Markets Board (SPK) ordered the liquidation of 130 investment funds run by seven portfolio managers — Tera, Pusula, Hedef, Atlas, A1, Pardus and Bulls — and suspended purchases and redemptions of those managers’ funds on the country’s electronic fund platform, after investors pulled as much as $1 billion from Turkish funds in a single day. The funds held about 891 billion lira, reported at $18.3 billion to $21.4 billion depending on the conversion, across roughly 353,000 investors. The SPK referred 38 people to prosecutors over manipulation of three affiliated stocks, courts jailed 20 and blocked 246 accounts on September 18, and executives’ assets were frozen on September 21.

The trigger was Pusula Portföy’s disclosure that it could not meet redemptions on time; Tera and Atlas followed. The underlying pattern, per the Financial Times and Reuters accounts, was funds buying large positions in thinly floated companies linked to them, which lifted fund values, attracted more money, and bought more of the same shares — two Pusula funds had returned 164% and 144% in the first seven months of 2026, and listed holding company Hedef briefly became Turkey’s second-largest company by market value. MSCI had warned about “coordinated trading behaviour” on June 24, 2026, S&P Dow Jones placed Turkey under review for a frontier-market cut on July 8, and the SPK’s late-August rules forcing funds to reduce concentrated positions started the unwind.

The Financial Stability Committee under Finance Minister Mehmet Şimşek met on September 17 and called the problem “temporary and manageable”; the central bank raised weekly repo funding to 300 billion lira and lifted interbank borrowing limits tenfold. On September 18 the SPK mandated Ziraat Bank and İşbank to run the liquidations, and on September 20 it extended the liquidation window from three months to six, citing the funds’ portfolio structures and market conditions. MSCI’s June statement said that without “tangible and credible progress” by the November 2026 Index Review it may launch a consultation on the treatment of Turkey and its securities.

Prices verified September 22, 2026: the BIST 100 fell from 14,235.8 on September 14 to 13,122.6 on September 16 (−7.8%) and was 13,196.6 on September 22, 12.8% below its May 11 high of 15,133.5. The banks index (XBANK) fell from 16,882 to 15,150 over the same two days and had fully recovered to 16,806 by September 22; Akbank closed at 73.05 lira against 72.55 on September 14, BİM at 432.25 against 429.75, Turkish Airlines at 298.5 against 295.5. Hedef Holding, at the centre of the affair, went from 36.34 lira on September 10 to 15.68 on September 22, falling the daily limit on most sessions. The iShares MSCI Turkey ETF closed at $37.64 on September 21 (September 16 low $36.18; May 11 high $43.74) and Turkcell’s ADR at $5.17 (September 16 low $4.93).

Opportunity

The obvious reading — a forced-seller opportunity in Turkish blue chips — was real for two sessions and is largely gone: the banks, the retailer and the airline are back where they were on September 14. What has not resolved is the thing that actually determines foreign flows into Turkey, which is not this week’s prices but whether MSCI and S&P Dow Jones keep the country in their emerging-market indexes. Turkey’s weight in MSCI Emerging Markets is small, but a demotion to frontier status would force passive and mandate-constrained emerging-market funds to sell every Turkish constituent, regardless of quality, over a defined window.

The mechanism cuts in a direction most coverage misses. MSCI’s complaint in June was precisely about coordinated trading in affiliated small caps inflating free-float estimates; what the SPK did between August 29 and September 21 — concentration limits, liquidation orders, criminal referrals, asset freezes, state banks running the wind-down — is the enforcement MSCI said it wanted to see. The crisis is the visible cost of the clean-up, and the clean-up is the evidence the index provider asked for. Meanwhile, a six-month liquidation run by two state banks means the selling in the affected names is orderly and dated rather than a fire sale.

Hypothesis: the market is treating the fund collapse as evidence for demotion when it may be evidence against it, and the November MSCI review is therefore a two-sided, dated event that the recovered large caps are not pricing either way. If MSCI reads the enforcement as progress and does not open a consultation, the overhang that has sat on Turkish equities since June lifts; if it opens one, the forced selling moves from a handful of manipulated small caps to the whole market in 2027. Which way it goes is a judgement about MSCI’s process, not about Turkish fundamentals, and that is researchable.

A second inference: the affected stocks (Hedef and the other affiliated companies) will be sold by Ziraat and İşbank on a schedule through roughly March 2027, so their prices are mechanically capped until then; the interesting question is whether any of them are real businesses at the prices the liquidation reaches.

How it could play out

The state-bank liquidations proceed through the autumn; the affiliated stocks keep falling until the sellers are done, while the index constituents trade on rates, inflation and the lira. MSCI’s November review either notes the enforcement and holds off on a consultation — in which case the discount that foreign investors have applied to Turkish equities since June starts to close and the market re-rates on Şimşek’s programme — or launches one, which would put a 2027 demotion on the calendar and trigger pre-emptive selling by index-benchmarked funds. S&P Dow Jones’ parallel review resolves on its own timetable.

The possible investment implication is a position in Turkish large caps (or the country ETF) sized to the November decision, with the affiliated small caps as a separate, later question once the state banks have finished selling; if MSCI consults, the same instruments are the short.

Questions worth asking

• Does the SPK’s enforcement since late August meet MSCI’s stated tests — ultimate-beneficial-ownership disclosure, monitoring of coordinated trading and a rules-based framework for distorted free floats — or does a fund run and a market halt itself count against Turkey’s accessibility score? Whoever answers that correctly has the November outcome.
• How much passive and benchmark-constrained money would have to leave if Turkey were reclassified to frontier, and over what window? The 2021 and 2023 precedents (Argentina, Pakistan) give the shape of the flow.
• Which BIST 100 constituents’ free-float estimates were inflated by the affiliated funds, and does removing them change the index composition even without a reclassification?
• Are any of the affiliated companies being liquidated real operating businesses, and at what price does a six-month forced sale by two state banks end?
• What did BBVA, which owns Garanti, say about the episode, and does the Turkish banking system carry any credit exposure to the savings-finance companies linked to the Pusula group that the state bank Emlak Katılım is now acquiring?
• Does the episode change the central bank’s path — it held at 37% on September 10, 2026 — and if lira liquidity injections have to persist, what does that do to the disinflation programme foreign investors were buying?

Where to look

• iShares MSCI Turkey ETF (TUR) — the liquid US-listed expression of the whole index question, $37.64 against a May high of $43.74
• Turkcell (TKC) — the largest Turkish ADR, useful for a US-hours expression of the same
• Akbank (AKBNK.IS), Garanti via BBVA (BBVA), Yapı Kredi (YKBNK.IS) — the banks that fell 10% and recovered in three days, and that any index flow moves first
• BİM (BIMAS.IS) and Turkish Airlines (THYAO.IS) — non-financial large caps foreign funds hold, both already back to pre-crisis prices
• Hedef Holding (HEDEF.IS) and the other affiliated companies named by the SPK — the liquidation targets, only interesting once the state banks have finished selling
• Ziraat Bank and İşbank (ISCTR.IS) — the mandated liquidators; how they sell sets the path for the affected names

Thesis check

The chain is strong where it is factual: the liquidation order, the six-month window, the state-bank mandate, the arrests and the MSCI and S&P Dow Jones warnings are all primary-sourced and dated, and the price data show cleanly that the blue-chip dislocation was two days long while the affiliated names are still falling. The weak link is the central judgement: whether MSCI’s methodology rewards enforcement that arrives via a market halt and a $20 billion fund run, or simply records that Turkey’s market became less accessible in September 2026 — the index provider’s process is opaque, its November decision could be a further deferral rather than a verdict, and a consultation would itself take months. A second constraint is that the large caps have already recovered, so the entry price for the optimistic case is no longer distressed; the asymmetry is in the index decision, not in the level.

Sources

Turkish Minute, Sep 17 2026 · Capital Markets Board of Türkiye (SPK) bulletin 2026/60, Sep 17 2026 · Business Standard, Sep 18 2026 · Turkish Minute, Sep 18 2026 · Daily Sabah, Sep 21 2026 · Bloomberg, Sep 21 2026 · Bloomberg, Jun 24 2026 · MSCI 2026 Market Classification Review press release, Jun 2026 · Turkish Minute, Jul 8 2026 · Balkan Insight, Sep 18 2026